Literature DB >> 16846590

Extending the nuclear roles of IkappaB kinase subunits.

Geoffrey Gloire1, Emmanuel Dejardin, Jacques Piette.   

Abstract

The transcription factor NF-kappaB plays a key role in a wide variety of cellular processes such as innate and adaptive immunity, cellular proliferation, apoptosis and development. In unstimulated cells, NF-kappaB is sequestered in the cytoplasm through its tight association with inhibitory proteins called IkappaBs, comprising notably IkappaBalpha. A key step in NF-kappaB activation is the phosphorylation of IkappaBalpha by the so-called IkappaB kinase (IKK) complex, which targets the inhibitory protein for proteasomal degradation and allows the freed NF-kappaB to enter the nucleus where it can transactivate its target genes. The IKK complex is composed of two catalytic subunits called IKKalpha and IKKbeta, and a regulatory subunit called NEMO/IKKgamma. Despite their key role in mediating IkappaBalpha phosphorylation in the cytoplasm, recent works have provided evidence that IKK subunits also translocate into the nucleus to regulate NF-kappaB-dependent and -independent gene expression, paving the way of a novel and exciting field of research. In this review, we will describe the current knowledge in that research area.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16846590     DOI: 10.1016/j.bcp.2006.06.017

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  20 in total

Review 1.  NF-κB addiction and its role in cancer: 'one size does not fit all'.

Authors:  M M Chaturvedi; B Sung; V R Yadav; R Kannappan; B B Aggarwal
Journal:  Oncogene       Date:  2010-12-20       Impact factor: 9.867

Review 2.  Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers.

Authors:  Sarah C Baumgarten; Jonna Frasor
Journal:  Mol Endocrinol       Date:  2012-02-02

Review 3.  Molecular pathways driving disease-specific alterations of intestinal epithelial cells.

Authors:  Rocío López-Posadas; Markus F Neurath; Imke Atreya
Journal:  Cell Mol Life Sci       Date:  2016-09-13       Impact factor: 9.261

4.  Bruton's tyrosine kinase phosphorylates Toll-like receptor 3 to initiate antiviral response.

Authors:  Koon-Guan Lee; Shengli Xu; Zi-Han Kang; Jianxin Huo; Mei Huang; Dingxiang Liu; Osamu Takeuchi; Shizuo Akira; Kong-Peng Lam
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-27       Impact factor: 11.205

5.  RNA-binding protein HuR regulates RGS4 mRNA stability in rabbit colonic smooth muscle cells.

Authors:  Fang Li; Danielle Y Hu; Shu Liu; Sunila Mahavadi; William Yen; Karnam S Murthy; Kamel Khalili; Wenhui Hu
Journal:  Am J Physiol Cell Physiol       Date:  2010-09-29       Impact factor: 4.249

6.  The IkappaB kinases IKKalpha and IKKbeta are necessary and sufficient for skeletal muscle atrophy.

Authors:  Darin Van Gammeren; Jeffrey S Damrauer; Robert W Jackman; Susan C Kandarian
Journal:  FASEB J       Date:  2008-09-30       Impact factor: 5.191

7.  A peptidyl-glucosamine derivative affects IKKalpha kinase activity in human chondrocytes.

Authors:  Anna Scotto d'Abusco; Laura Politi; Cesare Giordano; Roberto Scandurra
Journal:  Arthritis Res Ther       Date:  2010-01-29       Impact factor: 5.156

8.  Specification of the NF-kappaB transcriptional response by p65 phosphorylation and TNF-induced nuclear translocation of IKK epsilon.

Authors:  Rita Moreno; Jürgen-Markus Sobotzik; Christian Schultz; M Lienhard Schmitz
Journal:  Nucleic Acids Res       Date:  2010-05-27       Impact factor: 16.971

9.  Tumor necrosis factor-alpha (TNF-alpha) regulates Toll-like receptor 2 (TLR2) expression in microglia.

Authors:  Mohsin Md Syed; Nirmal K Phulwani; Tammy Kielian
Journal:  J Neurochem       Date:  2007-11       Impact factor: 5.372

10.  Proteasome inhibition by bortezomib increases IL-8 expression in androgen-independent prostate cancer cells: the role of IKKα.

Authors:  Subrata Manna; Bipradeb Singha; Sai Aung Phyo; Himavanth Reddy Gatla; Tzu-Pei Chang; Shannon Sanacora; Sitharam Ramaswami; Ivana Vancurova
Journal:  J Immunol       Date:  2013-07-26       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.